Pascal Soriot, chief executive of the Anglo-Swedish drugs company AstraZeneca, tells Andrew Hill about his 2014 battle to head off a hostile takeover bid from Pfizer of the US. <hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Pascal Soriot, chief executive of the Anglo-Swedish drugs company AstraZeneca, tells Andrew Hill about his 2014 battle to head off a hostile takeover bid from Pfizer of the US. Hosted on Acast. See acast.com/privacy for more information.

Pascal Soriot, chief executive of the Anglo-Swedish drugs company AstraZeneca, tells Andrew Hill about his 2014 battle to head off a hostile takeover bid from Pfizer of the US. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Leaders under pressure: Pascal Soriot 1/4

News features and analysis from Financial Times reporters around the world. FT News in Focus is produced by Fiona Symon. <hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

News

News Commentary

News features and analysis from Financial Times reporters around the world. FT News in Focus is produced by Fiona Symon. Hosted on Acast. See acast.com/privacy for more information.

News features and analysis from Financial Times reporters around the world. FT News in Focus is produced by Fiona Symon. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Share Leaders under pressure: Pascal Soriot 1/4

Sign up to save your podcasts

Leaders under pressure: Pascal Soriot 1/4

Leaders under pressure: Pascal Soriot 1/4